All News #Library
Quality
FDA approves Teva, MedinCell`s long-acting schizophrenia therapy
02 May 2023 //
FIERCE PHARMA
Teva and MedinCell Receive Complete Response Letter for TV-46000/mdc-IRM
20 Apr 2022 //
BUSINESSWIRE

Market Place
Sourcing Support